Table 2.

Levels of ALT, AST, Alb, and TBil in BDL model after carvedilol treatment for four weeks.

Group	ALT (U/L)	AST (U/L)	ALB (g/L)	TBil (μmol/L)
Sham	48.7 ± 6.24	136.9 ± 16.35	35.2 ± 3.12	1.39 ± 0.45
BDL	121.7 ± 15.33∗	603.9 ± 60.92∗	25.3 ± 5.06∗	141.2 ± 17.06∗
CAR-L	118.35 ± 14.93∗	586.32 ± 47.56∗	25.5 ± 4.12∗	135.6 ± 18.8∗
CAR-M	112.46 ± 16.89∗	552.1 ± 40.55∗#	26.09 ± 3.78∗	133.2 ± 16.32∗
CAR-H	105.2 ± 13.34∗#	519.6 ± 58.4∗#	27.1 ± 3.49∗	127.7 ± 13.06∗

BDL: bile duct ligation; sham: sham-operated; CAR: carvedilol; ALT: alanine transaminase; AST: aspartate transaminase; Alb: albumin; TBil: total bilirubin. ^∗P < 0.05  versus  sham; ^#P < 0.05  versus  BDL.